Designing dioscorea genomes for improved nutritional and pharmaceutical properties
Authors
Date Issued
Date Online
Language
Type
Review Status
Access Rights
Usage Rights
Metadata
Full item pageCitation
Bhattacharjee, R. (2023). Designing dioscorea genomes for improved nutritional and pharmaceutical properties. In C. Kole, Compendium of crop genome designing for nutraceuticals. Singapore: Springer, (p. 1589-1608).
Permanent link to cite or share this item
External link to download this item
Abstract/Description
Dioscorea species, commonly known as “Yams,” belong to family Dioscoreaceae consisting of about 600 species distributed from Africa, Asia, the Caribbean’s South America, and the South Pacific islands. The tuber of this genus is well known for their organoleptic properties, making them the most widely used food for carbohydrate, dietary supplements, and famine food. West Africa represents the region where yams are mostly consumed because of their underground and/or aerial tubers representing valuable sources of proteins, fats, and vitamins for millions of people. In addition to their nutritional properties, yams are the potential source of several bioactive compounds used in the treatment of many diseases, thus providing an opportunity for their use in pharmaceutical industries. However, the pharmaceutical properties of these bioactive compounds in yams need to be well researched and validated. Yams are known for the presence of secondary metabolites such as steroid saponin, allantoin, quinones, cyanidins, phenolics, and nitrogen-containing compounds as well as diosgenin representing different properties including antioxidant, hypoglycemic, hypolipidemic, antimicrobial, inflammatory, antiproliferative, androgenic, estrogenic, and contraceptive properties. This chapter summarizes the available information on nutritional and pharmaceutical properties of yams through published manuscripts and provides recommendations for future research directions for better utilization of yam tubers in human health and nutrition.